Vicki Moore, PhD

Contributing Writer https://www.cancertherapyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Gastrointestinal Cancers

Colorectal Liver Metastasis Linked to Chronic Hepatitis B Infection Status

Vicki Moore, PhD

October 17, 2019

A retrospective analysis of more than 7000 patients found a potential association between colorectal cancer, hepatic metastasis, and chronic HBV status.

Scanning electron micrograph of human bone, osteoporosis

General Oncology

ASCO Releases Guideline on Addressing Osteoporosis Risk With Nonmetastatic Cancer

Vicki Moore, PhD

October 15, 2019

The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures

Gynecologic Cancer

Oophorectomy More Effective Than Ultrasound Screening in Preventing BRCA1-Related Ovarian Cancer

Vicki Moore, PhD

September 26, 2019

Results of a prospective study comparing effectiveness of ultrasound screening and salpingo-oophorectomy in preventing ovarian cancer are presented.

General Oncology

Perceptions of Toxicity Burden for Patients Treated for Cancer Differ Among Clinicians

Vicki Moore, PhD

September 25, 2019

This study measured the difference between nurses’ and physicians’ perception of patients’ toxicity burden by symptom severity.

Multiple Myeloma

Nelfinavir Plus Lenalidomide, Dexamethasone Improves Response in Lenalidomide-Refractory Multiple Myeloma

Vicki Moore, PhD

September 13, 2019

Results of a phase 1/2 trial demonstrated the efficacy of nelfinavir in combination with lenalidomide and dexamethasone for lenalidomide-refractory MM.

Hematologic Cancers

Expert Panel Releases Recommendations on Unmet Clinical Needs With Ph-Negative Myeloproliferative Neoplasms

Vicki Moore, PhD

September 6, 2019

An overview of the findings of an expert panel that examined the unmet clinical needs for patients with Ph-negative MPNs to assess for risks of thrombosis.

Novel molecular technologies for detecting minimal residual disease may offer prognostic value.

Chronic Myeloid Leukemia

Outcomes With Nilotinib for Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Vicki Moore, PhD

September 5, 2019

Nilotinib was associated with high adherence to treatment and fairly high quality of life, and nearly all evaluated patients achieved a major molecular response.